doi.org/10.1182/blood.2020009039

Other

Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis

Camille V. Edwards

,

,

..., Andrew Eisenberger

Blood21.00

Volume: 138, Issue: 25, Pages: 2632 - 2641

Published: Sep 14, 2021

Paper Fields

Paper Details

Title

Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis

DOI

doi.org/10.1182/blood.2020009039

Published Date

Sep 14, 2021

Journal

Volume

138

Issue

25

Pages

2632 - 2641

Notes

History